Decreased Monocyte HLA-DR Expression in Patients with Sepsis and Acute Kidney Injury

Background and objectives: Acute kidney injury (AKI) is common in critically ill patients, especially those with sepsis. Persistently low human leukocyte antigen (HLA)-DR expression in monocytes reflects the decreased function of antigen-presenting cells, contributing to poor outcomes in sepsis. This study aimed to establish an association between AKI and HLA-DR expression in monocytes of patients with sepsis. Materials and Methods: We detected HLA-DR expression in monocytes and measured plasma levels of S100A12, high-mobility group box 1 (HMGB1), advanced glycation end products (AGE), and soluble receptor for AGE (sRAGE) from septic patients and healthy controls. Results: HLA-DR expression in monocytes was decreased in patients with AKI than in those without AKI (29.8 ± 5.0% vs. 53.1 ± 5.8%, p = 0.005). Compared with AKI patients, the mean monocyte HLA-DR expression in patients with end-stage renal disease was increased without statistical significance. There were no differences in the AGE/sRAGE ratio and plasma levels of S100A12, HMGB1, AGE, and sRAGE between patients with and without AKI. Conclusions: Compared with septic patients without AKI, patients with AKI had significantly lower HLA-DR expression in monocytes. The role of hemodialysis in monocyte HLA-DR expression needs further studies to explore.

[1]  S. Kaneko,et al.  Soluble receptor for advanced glycation end products protects from ischemia- and reperfusion-induced acute kidney injury , 2021, Biology open.

[2]  A. Mebazaa,et al.  Role of Damage-Associated Molecular Patterns in Septic Acute Kidney Injury, From Injury to Recovery , 2021, Frontiers in Immunology.

[3]  D. Nakano.  Septic acute kidney injury: a review of basic research , 2020, Clinical and Experimental Nephrology.

[4]  T. Rimmele,et al.  Monocytic HLA-DR expression kinetics in septic shock patients with different pathogens, sites of infection and adverse outcomes , 2020, Critical Care.

[5]  T. Evans,et al.  Plasma S100A8/A9 heterodimer is an early prognostic marker of acute kidney injury associated with cardiac surgery. , 2019, Biomarkers in medicine.

[6]  Zhongqing Chen,et al.  SIRT1-mediated HMGB1 deacetylation suppresses sepsis-associated acute kidney injury. , 2019, American journal of physiology. Renal physiology.

[7]  K. Prasad.  Is there any evidence that AGE/sRAGE is a universal biomarker/risk marker for diseases? , 2018, Molecular and Cellular Biochemistry.

[8]  Yin-ku Lin,et al.  Effect of Eucommia ulmoides Oliv., Gynostemma pentaphyllum (Thunb.) Makino, and Curcuma longa L. on Th1- and Th2-cytokine responses and human leukocyte antigen-DR expression in peripheral blood mononuclear cells of septic patients. , 2018, Journal of ethnopharmacology.

[9]  D. Tousoulis,et al.  The Role of Oxidative Stress , 2018 .

[10]  Hu Peng,et al.  Dynamic monitoring of monocyte HLA-DR expression for the diagnosis, prognosis, and prediction of sepsis. , 2017, Frontiers in bioscience.

[11]  Alan E. Jones,et al.  Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 , 2017, Intensive Care Medicine.

[12]  R. Bellomo,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[13]  A. Zarbock,et al.  Acute kidney injury: definition, diagnosis and epidemiology. , 2016, Minerva urologica e nefrologica = The Italian journal of urology and nephrology.

[14]  S. Yamagishi,et al.  Receptor for advanced glycation endproducts and progressive kidney disease , 2015, Current opinion in nephrology and hypertension.

[15]  A. Fabio,et al.  Soluble receptor for advanced glycation end products predicts 28-day mortality in critically ill patients with sepsis , 2013, Scandinavian journal of clinical and laboratory investigation.

[16]  A. Khwaja.  KDIGO Clinical Practice Guidelines for Acute Kidney Injury , 2012, Nephron Clinical Practice.

[17]  Yu-Chen Hou,et al.  Glutamine administration ameliorates sepsis-induced kidney injury by downregulating the high-mobility group box protein-1-mediated pathway in mice. , 2012, AJP - Renal Physiology.

[18]  Huang-Pin Wu,et al.  Serial increase of IL-12 response and human leukocyte antigen-DR expression in severe sepsis survivors , 2011, Critical care.

[19]  A. Lin,et al.  Changes of monocyte human leukocyte antigen-DR expression as a reliable predictor of mortality in severe sepsis , 2011, Critical care.

[20]  R. Pirracchio,et al.  Monocytic HLA‐DR expression in intensive care patients: Interest for prognosis and secondary infection prediction * , 2009, Critical care medicine.

[21]  C. Heizmann,et al.  Binding of S100 proteins to RAGE: an update. , 2009, Biochimica et biophysica acta.

[22]  C. Ronco,et al.  Oxidative Stress and ‘Monocyte Reprogramming’ in Septic Patients with Acute Kidney Injury Requiring CRRT , 2008, Blood Purification.

[23]  Joseph V Bonventre,et al.  Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. , 2005, Journal of the American Society of Nephrology : JASN.

[24]  V. Pettilä,et al.  Predictive value of interleukins 6, 8 and 10, and low HLA-DR expression in acute renal failure. , 2004, Clinical nephrology.

[25]  D M Linton,et al.  Severity of disease classification system. , 1991, Critical care medicine.

[26]  E. Draper,et al.  APACHE II: A severity of disease classification system , 1985, Critical care medicine.

[27]  W. Knaus,et al.  APACHE II: a severity of disease classification system. , 1985 .